Investing in Global Healthcare

Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments and transactions to account for complex and ever-shifting regulations.

Within this dynamic environment, our health lawyers wield a deep knowledge of how healthcare services, medical technology and pharmaceuticals are delivered around the world, and how the laws that affect those entities and that help drive action are creating the market of tomorrow.

Bringing this experience and commercial focus together we are proud to present the International Guide to Investing in Healthcare.

Looking forward to what’s on the horizon in 2022, our Healthcare and Life Sciences team have put together an addendum update to the Investing in Global Healthcare report. Please access the update here.

×

×

INVESTING IN HEALTHCARE REPORT

Use our interactive map to explore a summary of key facts and figures for the healthcare system in each European jurisdiction – Click and explore!
Access the full report and discover in each jurisdiction:
  • The impact of COVID-19
  • Regulation of the provision of healthcare services
  • Reimbursement and award of contracts
  • Drug approvals and reimbursement
  • Devices certification and reimbursement
  • Regulation of AI and medical device software
  • Telemedicine and teleconsultation
  • Anti-kickback rules and incentives to doctors
  • Merger and foreign investment control
  • Anticipated changes in healthcare and life sciences law

Click here to learn more about key healthcare investing developments in the United States, including significant growth in telehealth adoption, introduction of the CARES Act, expanded Medicaid coverage and increased investment in healthcare technology.

Click here to learn more about key healthcare investing developments in the United Arab Emirates, including market entry of foreign service providers, increased adoption of technology in healthcare and temporary fast-tracking of some administrative processes.

UAE country

Signature Events

HPE Europe

HPE Europe 2022

September 29, 2022

Thought leaders addressed cutting-edge deal strategies, health subsector insights, the latest and most important trends in health private equity (HPE) and vision from top HPE executives, investment bankers and lenders.

Learn More

pipette and test tubes

European Healthcare & Life Sciences Forum

October 18, 2022

This wide ranging discussion will on navigating cross border collaborations, insights for entering the US life sciences market as well as strategies for capitalizing on the growth of digital health.

Learn More

Resources

WSJ Intelligence Report
MWE-WSJ Logo Set

SEE WHAT’S IN STORE FOR THE FUTURE OF HEALTHCARE PRIVATE EQUITY

Investing in Healthcare and Life Sciences Guide

INTERNATIONAL INVESTING IN HEALTHCARE & LIFE SCIENCES

A guide to key legal and regulatory issues in health and life sciences transactions.

insights

latest developments arising from Brexit

navigate critical impacts of changing federal policies

thought leader perspectives on topics impacting the healthcare sector

HELPing YOU BREAK IN, BREAK THROUGH AND TRANSFORM HEALTHCARE DELIVERY

KEY CONTACTS

SHARON LAMB
United Kingdom

KRISTIAN WERLING
United States

Contributors

We would like to thank our contributors who have provided their market leading knowledge and industry acumen to complete this report.

SCHÖNHERR RECHTSANWÄLTE GMBH
Dr. Andreas Natterer
Austria

BECH BRUUN
Martin Dræbye Gantzhorn
Emil Kjeldahl Bjerregaard Bjerrum
Denmark

PORTOLANO CAVALLO STUDIO LEGALE
Elisa Stefanini
Marco Blei
Luca Gambini
Italy

HOUTHOFF
Greetje van Heezik
Jori de Goffau
Netherlands

WARDYŃSKI & PARTNERS
Joanna Krakowiak
Poland

GÓMEZ-ACEBO & POMBO ABOGADOS, S. L. P.
Irene Fernández Puyol
Spain

WALDER WYSS LTD.
Dr. Michael Isler
Christine Schweikard
Switzerland

XING


Related Site:     McDermott+ Consulting

Attorney Advertising ©2022 McDermott Will & Emery